Is a complete KYTX research report available?

No complete published report is available for Kyverna Therapeutics, Inc. (KYTX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Kyverna Therapeutics, Inc. (KYTX)

NASDAQ: KYTX · USD

$5.88

+0.25 (+4.4%)· Recorded snapshot

Market cap	363.6M
Net income (ttm)	-152.6M
EPS (ttm)	-$2.88
Shares out	61.8M
Volume	882,023
Beta	2.07

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -152.6M
EPS (ttm): -$2.88
Market cap: 363.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	持有

Metric	Value
Amount currency	USD
CIK code	0001994702
Company name	Kyverna Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	501976104
Earnings date	2026-11-11
Earnings time	amc
Employees	149
Employees change	20
Employees growth	15.5%
Enterprise value	$197.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2018
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2024-02-08
Is primary listing	Yes
Is SPAC	No
ISIN number	US5019761049
Last 10-K release date	2026-03-26
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$363.6M
Market cap category	Small-Cap
Next earnings date	2026-11-11
Options	Yes
Price	$5.88
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	KYTX
U.S. state	California
Website	https://kyvernatx.com

Metric

Value

Amount currency

USD

CIK code

0001994702

Company name

Kyverna Therapeutics, Inc.

Country

United States

Country code

CUSIP number

501976104

Earnings date

2026-11-11

Earnings time

amc

Employees

149

Employees change

Employees growth

15.5%

Enterprise value

$197.2M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2018

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2024-02-08

Is primary listing

Yes

Is SPAC

ISIN number

US5019761049

Last 10-K release date

2026-03-26

Last earnings date

2026-08-11

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$363.6M

Market cap category

Small-Cap

Next earnings date

2026-11-11

Options

Yes

Price

$5.88

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

KYTX

U.S. state

California

Website

https://kyvernatx.com

Metric	Value
Earnings yield	-48.99%
FCF / EV yield	-80.9%
FCF yield	-43.81%
Forward EV/Sales	77.8x
Forward P/S	143.66x
P/B ratio	2.09x
Price / tangible book value	2.19x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-48.99%

FCF / EV yield

-80.9%

FCF yield

-43.81%

Forward EV/Sales

77.8x

Forward P/S

143.66x

P/B ratio

2.09x

Price / tangible book value

2.19x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-1M
ROA	-44.51%
ROCE	-80.67%
ROE	-87.24%
ROIC	-51.09%

Metric

Value

Profit per employee

$-1M

ROA

-44.51%

ROCE

-80.67%

ROE

-87.24%

ROIC

-51.09%

Metric	Value
EPS growth quarters	3
EPS growth years	0
Net income growth quarters	2
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-294,000
Depreciation and amortization	$1.6M
EBIT	$-158.9M
EBITDA	$-157.4M
EPS	$-2.88
FCF per share	$-2.57
Financing cash flow	$145.9M
Free cash flow	$-159M
Free cash flow minus SBC	$-171.1M
Investing cash flow	$-8.8M
Net borrowing	$24.3M
Net cash flow	$-21.6M
Net income	$-152.6M
Operating cash flow minus SBC	$-170.8M
Operating income	$-158.9M
Stock-based compensation	$12.1M

Metric

Value

Capital expenditures

$-294,000

Depreciation and amortization

$1.6M

EBIT

$-158.9M

EBITDA

$-157.4M

EPS

$-2.88

FCF per share

$-2.57

Financing cash flow

$145.9M

Free cash flow

$-159M

Free cash flow minus SBC

$-171.1M

Investing cash flow

$-8.8M

Net borrowing

$24.3M

Net cash flow

$-21.6M

Net income

$-152.6M

Operating cash flow minus SBC

$-170.8M

Operating income

$-158.9M

Stock-based compensation

$12.1M

Metric	Value
Book value per share	$2.69
Debt / equity	0.2
Interest coverage	-88.69
Long-term assets	$13.3M
Long-term liabilities	$31.5M
Net cash (debt)	$166.4M
Net cash / market cap	45.85%
Net cash growth	-19.11%
Net debt / equity	-1.01
Piotroski F-Score	1
Property, plant and equipment	$9.3M
Shareholders' equity	$165.5M
Tangible book value	$165.5M
Tangible book value per share	$2.69
Total assets	$219.8M
Total cash	$199.4M
Total debt	$33M
Total liabilities	$54.3M
WACC	14.67%

Metric

Value

Book value per share

$2.69

Debt / equity

0.2

Interest coverage

-88.69

Long-term assets

$13.3M

Long-term liabilities

$31.5M

Net cash (debt)

$166.4M

Net cash / market cap

45.85%

Net cash growth

-19.11%

Net debt / equity

-1.01

Piotroski F-Score

Property, plant and equipment

$9.3M

Shareholders' equity

$165.5M

Tangible book value

$165.5M

Tangible book value per share

$2.69

Total assets

$219.8M

Total cash

$199.4M

Total debt

$33M

Total liabilities

$54.3M

WACC

14.67%

Metric	Value
Current assets	$206.5M
Current liabilities	$22.8M
Current ratio	9.06
Net working capital	$-14.2M
Quick ratio	8.75
Working capital	$183.7M

Metric

Value

Current assets

$206.5M

Current liabilities

$22.8M

Current ratio

9.06

Net working capital

$-14.2M

Quick ratio

8.75

Working capital

$183.7M

Metric	Value
Buyback yield / dilution	-22.58%
Dividend yield	0%
Shareholder yield	-22.58%

Metric

Value

Buyback yield / dilution

-22.58%

Dividend yield

Shareholder yield

-22.58%

Metric	Value
150-day SMA	$8.04
1D price change	4.44%
1M price change	-14.1%
1M total return	-14.1%
1W price change	-3.15%
1W total return	-3.15%
1Y price change	-25.1%
1Y return CAGR	-25.11%
1Y total return	-25.1%
20-day SMA	$5.94
200-day SMA	$8.12
3M price change	-26.14%
3M total return	-26.14%
50-day SMA	$7.01
50-day SMA vs 200-day SMA	50under200
52-week high	$13.67
52-week high date	2025-12-15
52-week low	$5.16
52-week low date	2026-10-27
6M price change	-34.93%
6M total return	-34.93%
All-time high	$35.06
All-time high date	2024-02-08
All-time low	$1.78
All-time low date	2025-04-17
Average true range (ATR)	$0.38
Average volume	850.9K
Beta (1Y)	2.05
Beta (2Y)	1.86
Beta (5Y)	2.07
Change from 52-week high	-56.99%
Change from 52-week low	13.95%
Change from all-time high	-83.31%
Change from all-time low	228.65%
Change from open	5%
Day's gap	-0.53%
Dollar volume	$5.2M
High price	$5.94
Low price	$5.60
Monthly RSI	31.9
Open price	$5.60
Position in 52-week range	82.35%
Premarket change	-0.71%
Premarket close	$5.63
Premarket price	$5.59
Previous close	$5.63
Price vs 150-day SMA	-27.26%
Price vs 20-day SMA	-1.55%
Price vs 200-day SMA	-27.96%
Price vs 50-day SMA	-16.6%
Relative volume	1.04
Return from IPO open	-82.86%
Return from IPO price	-73.32%
RSI	43.57
Sharpe ratio	0.08
Sortino ratio	0.17
Volume	882K
Weekly RSI	37.81
YTD price change	-37.77%
YTD total return	-37.77%

Metric

Value

150-day SMA

$8.04

1D price change

4.44%

1M price change

-14.1%

1M total return

-14.1%

1W price change

-3.15%

1W total return

-3.15%

1Y price change

-25.1%

1Y return CAGR

-25.11%

1Y total return

-25.1%

20-day SMA

$5.94

200-day SMA

$8.12

3M price change

-26.14%

3M total return

-26.14%

50-day SMA

$7.01

50-day SMA vs 200-day SMA

50under200

52-week high

$13.67

52-week high date

2025-12-15

52-week low

$5.16

52-week low date

2026-10-27

6M price change

-34.93%

6M total return

-34.93%

All-time high

$35.06

All-time high date

2024-02-08

All-time low

$1.78

All-time low date

2025-04-17

Average true range (ATR)

$0.38

Average volume

850.9K

Beta (1Y)

2.05

Beta (2Y)

1.86

Beta (5Y)

2.07

Change from 52-week high

-56.99%

Change from 52-week low

13.95%

Change from all-time high

-83.31%

Change from all-time low

228.65%

Change from open

Day's gap

-0.53%

Dollar volume

$5.2M

High price

$5.94

Low price

$5.60

Monthly RSI

31.9

Open price

$5.60

Position in 52-week range

82.35%

Premarket change

-0.71%

Premarket close

$5.63

Premarket price

$5.59

Previous close

$5.63

Price vs 150-day SMA

-27.26%

Price vs 20-day SMA

-1.55%

Price vs 200-day SMA

-27.96%

Price vs 50-day SMA

-16.6%

Relative volume

1.04

Return from IPO open

-82.86%

Return from IPO price

-73.32%

RSI

43.57

Sharpe ratio

0.08

Sortino ratio

0.17

Volume

882K

Weekly RSI

37.81

YTD price change

-37.77%

YTD total return

-37.77%

Metric	Value
Float	36.1M
Float percentage	58.32%
Shares change (QoQ)	0.77%
Shares change (YoY)	22.58%
Shares held by insiders	1.79%
Shares held by institutions	44.52%
Shares outstanding	61.8M
Short % of float	26.46%
Short % of shares	15.43%
Short ratio	10.2 days

Metric

Value

Float

36.1M

Float percentage

58.32%

Shares change (QoQ)

0.77%

Shares change (YoY)

22.58%

Shares held by insiders

1.79%

Shares held by institutions

44.52%

Shares outstanding

61.8M

Short % of float

26.46%

Short % of shares

15.43%

Short ratio

10.2 days

Kyverna Therapeutics, Inc. (KYTX)

Price

Financial snapshot

Fair-value bridge

Latest news · KYTX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All KYTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on KYTX

Frequently asked questions